β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
Abstract Background Effects of β-blockers on outcomes in patients with chronic heart failure (CHF) and atrial fibrillation (AF) is still in controversy. Methods Searching was conducted by using keywords “atrial fibrillation”, and “heart failure” in PubMed, MEDLINE and Embase databases before Novembe...
Main Authors: | Tianyu Xu, Yuli Huang, Haobin Zhou, Yujia Bai, Xingfu Huang, Yunzhao Hu, Dingli Xu, Yuhui Zhang, Jian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-019-1079-2 |
Similar Items
-
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry
by: Tommaso Bucci, et al.
Published: (2024-04-01) -
Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
by: Mohamed Zeinah, et al.
Published: (2016-06-01) -
Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
by: Hebah Hassan, BS, et al.
Published: (2020-06-01) -
Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Dimitra Vlachopoulou, et al.
Published: (2023-04-01) -
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
by: Teruhiko Imamura, et al.
Published: (2020-10-01)